The tissue transglutaminase (TG) test only focuses on celiac disease as the primary autoimmune illness. Gluten, a protein found in wheat, barley, rye, and oats, is attacked by the immune system in celiac disease as a foreign intruder. The next target of antibodies is Tissue Transglutaminase (TG), a calcium-dependent enzyme that restricts proteolysis and is commonly found in the intestines.
Autoimmune reactions are brought on by the antibodies immunoglobulin A (IgA) and immunoglobulin G. (IgG). The TG antibody's IgA variant is more routinely utilised to diagnose celiac disease. due to the fact that it is produced in the small intestine, which irritates sensitive people who have gluten sensitivities.
Between 2022 and 2030, the Tissue Transglutaminase Test Market is anticipated to expand at a CAGR of 18.9%. The rising frequency of celiac disease and an ageing population are the two main drivers mentioned in the global tissue transglutaminase testing market report. False positive diagnoses in the elderly population are a market growth inhibitor.
Global Tissue Transglutaminase Test Market –Competitive Landscape
The global tissue transglutaminase test market is observed to be growing upwards due to the technological advancements of key players like Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, and Bio-Rad Laboratories, Inc., Pfizer Inc., Amgen Inc., Ajinomoto Co, Inc., Yiming Biological Products Co., Ltd., Micro-Tech Foods Ingredients, Inc, Kinry Food Ingredients Co., Ltd., Nanning Pangbo Biological Engineering Co., Ltd., and BioRap Technologies Ltd.
The well-established market players are involved in strategic collaborations and new product launches to gain an edge over other competitors in this market.
Some of the market participants for tissue transglutaminase tests include Quest Diagnostics Incorporated, SQI Diagnostics, Trinity Biotech, Zedira GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, and Bio-Rad Laboratories, Inc. Other participants include Pfizer Inc., Amgen Inc., Ajinomoto Co., Inc., Yiming Biological Products Co., Ltd., Micro-Tech Foods Ingredients
Regional Analysis
The tissue transglutaminase test market is segmented into the Americas, Europe, Asia-Pacific and Middle East Africa.
The Americas account for a significant market share owing to high usage of medications and high expenditure on the health care facilities and products. Moreover, the fast uptake of new technological advancements in the United States drive the global tissue transglutaminase test market. Additionally, the concentration of major research companies and research organizations in the developed countries of this region boost the market growth.
Europe is the second largest market in the world. This is because of high income and healthcare penetration in the region.
Asia Pacific region is expected to grow speedily, shows our tissue transglutaminase testing market research. Some of the countries in this region, namely India and China are expected to lead this market due to fast growing healthcare sector during the forecast period.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
